AGE AgeX Therapeutics Inc

0.0281 (3.84%)
Last Updated: 14:07:48
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 3,046
Bid Price
Ask Price
News -
Day High 0.76


52 Week Range


Day Low 0.71
Company Name Stock Ticker Symbol Market Type
AgeX Therapeutics Inc AGE AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0281 3.84% 0.76 14:07:48
Open Price Low Price High Price Close Price Prev Close
0.71 0.71 0.76 0.7319
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
52 3,046 $ 0.7448327 $ 2,269 - 0.372 - 1.00
Last Trade Time Type Quantity Stock Price Currency
14:07:19 1 $ 0.7611 USD

AgeX Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
28.84M 37.95M - 34k -10.46M -0.28 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

AgeX Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No AGE Message Board. Create One! See More Posts on AGE Message Board See More Message Board Posts

Historical AGE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.69030.840.68710.785827133,8490.069710.1%
1 Month0.73010.840.63330.753640526,0080.02994.1%
3 Months0.910.93810.63330.761772624,752-0.15-16.48%
6 Months0.661.000.3720.679148323,5430.1015.15%
1 Year0.5961.000.3720.65259823,4900.16427.52%
3 Years0.93753.930.3722.21599,608-0.1775-18.93%
5 Years1.135.950.3722.16441,645-0.37-32.74%

AgeX Therapeutics Description

AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.